 Heidelberg, Germany, May 20, 2021 Affimed N.V. Nasdaq: AFMD, a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that its 2021 Annual General Meeting of Shareholders the Annual Meeting will be held on June 15, 2021 at 17:30 PM CET 11:30 AM EDT. Due to the continuing COVID-19 pandemic and out of concern for the health and safety of shareholders and other attendees, the Annual Meeting will be held virtually and can be followed by visiting , in accordance with the instructions provided in the notice of the meeting. Shareholders will not be able to attend the Annual Meeting in person. 